Snowball logo
logo
ZLSC

ZYUS Life Sciences Corporation

ZLSCF • OTCGREY
$0.60$0.00  (0%)
Estimate
EPS
-0.18
Beta
0.456
Growth
Revenue, YoY
-35.29%
Net income, YoY
33.97%
FCF, YoY
38.23%
About the company
Ticker
ZLSCF
ISIN
CA9899601095
Country
Canada
Sector (GICS)
Healthcare
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.

Frequently asked questions

What sector does ZYUS Life Sciences Corporation (ZLSCF) operate in?

ZYUS Life Sciences Corporation belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is ZYUS Life Sciences Corporation (ZLSCF) current stock price?

As of the latest data, ZYUS Life Sciences Corporation stock price is $0.60, with a previous close of $0.60.

What is ZYUS Life Sciences Corporation (ZLSCF) current market capitalization?

ZYUS Life Sciences Corporation market cap is approximately 48.04 million.

What is ZYUS Life Sciences Corporation (ZLSCF) Earnings Per Share (EPS)?

The trailing EPS is -$0.18.

What is ZYUS Life Sciences Corporation (ZLSCF) EBITDA?

ZYUS Life Sciences Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.48 million.

Does ZYUS Life Sciences Corporation (ZLSCF) pay dividends?

No. ZYUS Life Sciences Corporation does not pay a dividend.

What is ZYUS Life Sciences Corporation (ZLSCF) beta (volatility) score?

ZYUS Life Sciences Corporation has a beta of 0.456, indicating lower volatility than the overall market.